Sammanfattning
In this issue of Blood, Matsumoto et al report that T cell-specific deletion of the cyclin-dependent kinase inhibitor p57Kip2(p57) in mice leads to a block in T-cell development as a result of hyperactivation of the E2F-p53 pathway and demonstrate that the loss of p57 accelerates lymphomagenesis in the absence of p53.
Originalspråk | engelska |
---|---|
Sidor (från-till) | 3370-3371 |
Tidskrift | Blood |
Volym | 123 |
Nummer | 22 |
DOI | |
Status | Published - 2014 maj 29 |
Externt publicerad | Ja |